Sort   by:  
 Page size 
UnknownCD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
Not available
S-EPMC5549451 | biostudies-literature
UnknownCD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients.
Not available
S-EPMC7199442 | biostudies-literature
UnknownCytokine-mediated CAR T therapy resistance in AML.
Not available
S-EPMC12118809 | biostudies-literature
UnknownGenetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
Not available
S-EPMC12405866 | biostudies-literature
Sort   by:  
 Page size